Published in Nutr Cancer on January 01, 2000
Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17
Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev (2010) 1.05
Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol (2008) 1.04
Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst (2003) 0.99
Macronutrients, vitamins and minerals intake and risk of esophageal squamous cell carcinoma: a case-control study in Iran. Nutr J (2011) 0.98
Vegetable and fruit intakes and risk of Barrett's esophagus in men and women. Am J Clin Nutr (2009) 0.93
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer (2008) 0.89
A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus. J Clin Pathol (2005) 0.85
Toenail selenium status and the risk of Barrett's esophagus: the Netherlands Cohort Study. Cancer Causes Control (2010) 0.85
Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut (2007) 0.79
Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature. Curr Nutr Rep (2015) 0.77
Genetic control of the cell division cycle in yeast. Science (1974) 13.83
Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol (1999) 10.36
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
A p53-dependent mouse spindle checkpoint. Science (1995) 4.01
Regulation of mating in the cell cycle of Saccharomyces cerevisiae. J Cell Biol (1977) 3.68
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet (1999) 3.30
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med (2002) 3.21
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol (2000) 2.99
Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol (1995) 2.73
Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol (2000) 2.58
Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology (1992) 2.57
17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A (1996) 2.53
The impact of the acquired immunodeficiency syndrome on patterns of premature death in New York City. JAMA (1986) 2.49
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology (1992) 2.48
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (1998) 2.43
Selected methodological issues in evaluating community-based health promotion and disease prevention programs. Annu Rev Public Health (1992) 2.26
Asian breast cancer survival in the US: a comparison between Asian immigrants, US-born Asian Americans and Caucasians. Int J Epidemiol (2001) 2.23
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol (2001) 2.17
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology (1987) 2.15
Estimating relative risk functions in case-control studies using a nonparametric logistic regression. Am J Epidemiol (1996) 2.13
Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res (2000) 2.13
Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2001) 2.13
Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst (2000) 2.07
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05
Work-site smoking policies: their population impact in Washington State. Am J Public Health (1993) 2.03
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology (1992) 2.03
Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology (1993) 2.00
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control (2000) 2.00
Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol (1986) 1.91
Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. Genome Res (1999) 1.90
Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest (1989) 1.83
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1996) 1.82
Application of a behavioral approach to measuring dietary change: the fat- and fiber-related diet behavior questionnaire. Cancer Epidemiol Biomarkers Prev (1997) 1.78
Vitamin supplements and cancer risk: the epidemiologic evidence. Cancer Causes Control (1997) 1.75
Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A (1995) 1.75
Effects of physical activity intensity, frequency, and activity type on 10-y weight change in middle-aged men and women. Int J Obes (Lond) (2005) 1.72
Demographic and psychosocial predictors of fruit and vegetable intakes differ: implications for dietary interventions. J Am Diet Assoc (1998) 1.70
Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials. Nutr Cancer (2001) 1.69
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res (1997) 1.67
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65
Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial. Gastroenterology (1998) 1.65
p53-mutant clones and field effects in Barrett's esophagus. Cancer Res (1999) 1.61
Methodologic studies during pregnancy: the reliability of the 24-hour dietary recall. Am J Clin Nutr (1982) 1.61
c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology (1990) 1.59
Histological and anatomic changes in Barrett's esophagus after antireflux surgery. Am J Gastroenterol (1999) 1.59
The effect of keeping food records on eating patterns. J Am Diet Assoc (1998) 1.58
Use of food nutrition labels is associated with lower fat intake. J Am Diet Assoc (1999) 1.58
An application of the stage model of behavior change to dietary fat reduction. Health Educ Res (1992) 1.58
Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol (1999) 1.56
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
A neural network theory of proportional analogy-making. Neural Netw (2000) 1.53
Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci U S A (1991) 1.53
17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res (1994) 1.52
A dietary intervention in primary care practice: the Eating Patterns Study. Am J Public Health (1997) 1.52
Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol (1998) 1.52
Occupation, socioeconomic status, and brain tumor mortality: a death certificate-based case-control study. J Occup Med (1991) 1.51
Socioeconomic status and the incidence of multiple myeloma. Epidemiology (1996) 1.49
Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res (1994) 1.49
Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene (1996) 1.46
Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative. Public Health Nutr (1999) 1.45
Using a brief household food inventory as an environmental indicator of individual dietary practices. Am J Public Health (1997) 1.44
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44
p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology (1994) 1.43
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res (1991) 1.39
Barrett's esophagus: ordering the events that lead to cancer. Eur J Cancer Prev (1996) 1.39
Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control (1996) 1.35
Association of awareness, intrapersonal and interpersonal factors, and stage of dietary change with fruit and vegetable consumption: a national survey. Am J Health Promot (2001) 1.33
Validity of short food frequency questionnaires used in cancer chemoprevention trials: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev (1999) 1.33
Formaldehyde and cancers of the pharynx, sinus and nasal cavity: I. Occupational exposures. Int J Cancer (1986) 1.32
Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene (1996) 1.32
Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer (2001) 1.29
Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst (1990) 1.27
Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol (2000) 1.25
Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay. Histopathology (1990) 1.24
Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res (1995) 1.24
Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology (1998) 1.24
Stages of change in adopting healthy diets: fat, fiber, and correlates of nutrient intake. Health Educ Q (1994) 1.22
A case-control study of maternal smoking and congenital malformations. Paediatr Perinat Epidemiol (1990) 1.20
Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents. J Nutr (2001) 1.20
Development of scales to measure dietary acculturation among Chinese-Americans and Chinese-Canadians. J Am Diet Assoc (2001) 1.19
Formaldehyde and cancers of the pharynx, sinus and nasal cavity: II. Residential exposures. Int J Cancer (1986) 1.19
Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids. Eur J Clin Nutr (2011) 1.19
Correlates of maintenance of a low-fat diet among women in the Women's Health Trial. Prev Med (1992) 1.14
Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res (1996) 1.14
Do beliefs, knowledge, and perceived norms about diet and cancer predict dietary change? Am J Public Health (1996) 1.13
Fetal death and maternal occupation. An analysis of birth records in the State of Washington. J Occup Med (1984) 1.13
Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst (1996) 1.13